Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2851561rdf:typepubmed:Citationlld:pubmed
pubmed-article:2851561lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:2851561lifeskim:mentionsumls-concept:C0014298lld:lifeskim
pubmed-article:2851561lifeskim:mentionsumls-concept:C0140057lld:lifeskim
pubmed-article:2851561lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:2851561pubmed:issue1lld:pubmed
pubmed-article:2851561pubmed:dateCreated1989-3-23lld:pubmed
pubmed-article:2851561pubmed:abstractTextIn order to assess the individual effects of each of the 3-methyl groups in residue 2 of [D-Pen2, D-Pen5]enkephalin on binding affinity to mu and delta opioid receptors, (2S,3S)methylcysteine ((3S)Me-D-Cys) and (2S,3R)methylcysteine ((3R)Me-D-Cys) were synthesized and incorporated into the analogs, [(3S)Me-D-Cys2, D-Pen5] enkephalin and [(3R)Me-D-Cys2, D-Pen5]enkephalin. Of these analogs, [(3S)Me-D-Cys2, D-Pen5]enkephalin appears from 1H n.m.r. spectra to assume a conformation similar to those of [D-Pen2, D-Pen5]enkephalin and the less delta receptor-selective, but more potent, [D-Cys2, D-Pen5]enkephalin. Assessment of binding affinity to mu and delta receptors revealed that [(3S)Me-D-Cys2, D-Pen5]enkephalin exhibits delta receptor affinity intermediate between [D-Pen2, D-Pen5]enkephalin and [D-Cys2, D-Pen5]enkephalin while its mu receptor affinity is similar to that of [D-Cys2, D-Pen5]enkephalin. These results suggest that, for [D-Pen2, D-Pen5]enkephalin, adverse steric interactions between the D-Pen2 pro-R methyl group and the mu receptor binding site lead to the low mu receptor binding affinity observed for this analog. By contrast, both the pro-R and pro-S D-Pen2 methyl groups lead to minor steric interactions which contribute to the somewhat lower delta receptor affinity of this compound.lld:pubmed
pubmed-article:2851561pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:languageenglld:pubmed
pubmed-article:2851561pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:citationSubsetIMlld:pubmed
pubmed-article:2851561pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2851561pubmed:statusMEDLINElld:pubmed
pubmed-article:2851561pubmed:monthJullld:pubmed
pubmed-article:2851561pubmed:issn0367-8377lld:pubmed
pubmed-article:2851561pubmed:authorpubmed-author:MosbergH IHIlld:pubmed
pubmed-article:2851561pubmed:authorpubmed-author:AkilHHlld:pubmed
pubmed-article:2851561pubmed:authorpubmed-author:RamalingamKKlld:pubmed
pubmed-article:2851561pubmed:authorpubmed-author:MansourAAlld:pubmed
pubmed-article:2851561pubmed:authorpubmed-author:WoodardR WRWlld:pubmed
pubmed-article:2851561pubmed:authorpubmed-author:HaasethR CRClld:pubmed
pubmed-article:2851561pubmed:issnTypePrintlld:pubmed
pubmed-article:2851561pubmed:volume32lld:pubmed
pubmed-article:2851561pubmed:ownerNLMlld:pubmed
pubmed-article:2851561pubmed:authorsCompleteYlld:pubmed
pubmed-article:2851561pubmed:pagination1-8lld:pubmed
pubmed-article:2851561pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:meshHeadingpubmed-meshheading:2851561-...lld:pubmed
pubmed-article:2851561pubmed:year1988lld:pubmed
pubmed-article:2851561pubmed:articleTitleRole of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalin.lld:pubmed
pubmed-article:2851561pubmed:affiliationCollege of Pharmacy, University of Michigan, Ann Arbor.lld:pubmed
pubmed-article:2851561pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2851561pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2851561lld:pubmed